MACK Stock Price, Chart, Stats & News

Merrimack Pharmaceuticals, Inc.
Save
Merrimack Pharmaceuticals, Inc. (MACK) is a dividend-paying stock with a current dividend yield of 0.00% as of May 17, 2024. It pays $0 per share over the trailing twelve months.
Dividend safety
Strong
Dividend coverage looks healthy — MACK pays out about 0% of earnings.
MACK chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -1.03% |
ROA | -6.15% |
ROE | -6.22% |
D/E | – |
Interest coverage ratio | – |
MACK valuation
P/E | – |
P/S | – |
P/B | 11.55x |
P/CF | -142.29x |
P/FCF | -147.16x |
P/OCF | -142.29x |
PEG | -1.83x |
EV multiple | 228.36x |
About
Founded in 1993, Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts.
Similar securities
Based on sector and market capitalization
Report issue











